glp-1 ncbi Emerging Frontiers in Therapeutics: A Comprehensive Evidence Base (2025) Why are GLP-1 agonists being

In June 2024, the company announced a new $4.1 billion manufacturing site in Clayton, North Carolina, on a 56-acre campus ( [5] )

Inflamm Bowel Dis 2024 Nov 27 [Epub]

According to the Asia Development Bank, in May 2024, Asia Pacific is projected to experience a significant demographic shift, with the population of individuals aged 60 and above nearly doubling to reach 1.2 billion by 2050

HW TIPS TO MINIMIZE GI SIDE EFFECTS One or more gastrointestinal (GI) side effects are observed in roughly 10% to 50% of people who take one of these weight management medications.1,2 From nausea and vomiting to acid reflux, bloating, stomach cramps, diarrhea, and/or constipation, patients can minimize GI side effects with a start low, go slow approach, starting with the lowest dose and titrating as recommended (see table Currently FDA-Approved Mono and Dual Agonists)